Management of acne

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 7, 2011, Pages

  Kraft, John ^a   Freiman, Anatoli ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ALUMINUM CHLORIDE; ANABOLIC AGENT; ANDROGEN; AYURVEDIC DRUG; BENZOYL PEROXIDE; BUTENAFINE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIANE; DOXYCYCLINE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ERYTHROMYCIN; GENTLE FORMULA; ISONIAZID; ISOTRETINOIN; LITHIUM; MINOCYCLINE; PHENYTOIN; PROACTIV; RESORCINOL; RETINOIC ACID; RETINOID; SALICYLIC ACID; SPIRONOLACTONE; SULFUR; TAZAROTENE; TEA TREE OIL; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC;

ACNE VULGARIS; ALTERNATIVE MEDICINE; ANTIBIOTIC RESISTANCE; BLOOD DYSCRASIA; BLUE LIGHT; CHILD CARE; DEPRESSION; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRY EYE; DRY NOSE; DYSKERATOSIS; EPIPHYSIS DISEASE; ERYTHEMA; ERYTHEMA MULTIFORME; EVENING DOSAGE; FOLLICULITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; HYPERANDROGENISM; HYPERKALEMIA; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; KERATOSIS; LIVER TOXICITY; LOW LEVEL LASER THERAPY; LUPUS LIKE SYNDROME; MEDICAL DECISION MAKING; MENSTRUAL IRREGULARITY; META ANALYSIS (TOPIC); MORNING DOSAGE; MULTICENTER STUDY (TOPIC); NIGHT BLINDNESS; PANCREATITIS; PATHOGENESIS; PATIENT COMPLIANCE; PERIORAL DERMATITIS; PERSONAL HYGIENE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PREGNANCY; PROPIONIBACTERIUM ACNES; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SEBUM SECRETION; SIDE EFFECT; SKIN ABRASION; SKIN IRRITATION; SKIN PIGMENTATION; STEVENS JOHNSON SYNDROME; SUICIDAL IDEATION; TERATOGENICITY; TOXIC EPIDERMAL NECROLYSIS;

EID: 79955137591     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090374     Document Type: Review

References (48)

1. Magin P, Adams J, Heading G, et al. Psychological sequelae of acne vulgaris: Results of a qualitative study. Can Fam Physician 2006;52:978-9. (Pubitemid 44449094)
2. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004;292:726-35. (Pubitemid 39062528)
3. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007;56:651-63. (Pubitemid 46400177)
4. James WD. Acne. N Engl J Med 2005;352:1463-72.
5. American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee. American Association of Clinical Endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome. Endocr Pract 2005;11:126-34.
6. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49(Suppl 1): S1-37. (Pubitemid 36791495)
7. Webster GF, Guenther L, Poulin YP, et al. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis 2002; 69 (Suppl):4-11.
8. Cunliffe WJ, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel vs tretinoin 0.025% gel in patients with acne vulgaris: A meta analysis of five randomized trials. Br J Dermatol 1998;139(suppl 52):48-56.
9. Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol 1992;17:165-8.
10. Mills OH Jr, Kligman AM, Pochi P, et al. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 1986;25:664-7. (Pubitemid 17210594)
11. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978;70:51-5. (Pubitemid 8262275)
12. Cunliffe WJ, Holland KT, Bojar R, et al. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther 2002;24:1117-33. (Pubitemid 34833234)
13. Zouboulis CC, Derumeaux L, Decroix J, et al. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. Br J Dermatol 2000; 143: 498-505.
14. Handojo I. The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris. Int J Dermatol 1979;18:489-96. (Pubitemid 10240787)
15. Wolf JE Jr, Kaplan D, Kraus SJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized investigator blinded study. J Am Acad Dermatol 2003;49:S211-7. (Pubitemid 37046535)
16. Ellis CN, Leyden J, Katz HI, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis 2001;67(Suppl 2): 13-20.
17. Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008;27:170-6.
18. Burkhart CG, Burkhart CN. Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution). Int J Dermatol 2007;46:89-93. (Pubitemid 46029733)
19. Magin P, Pond D, Smith W, et al. A systematic review of the evidence for 'myths and misconceptions' in acne management: diet, face-washing and sunlight. Fam Pract 2005;22:62-70. (Pubitemid 40309607)
20. Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005;11:204-13. (Pubitemid 40352767)
21. Masters PA, O'Bryan TA, Zurlo J, et al. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 2003;163:402-10. (Pubitemid 36241016)
22. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: Randomized controlled trial. Lancet 2004;364:2188-95. (Pubitemid 40018448)
23. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with treatment failure. Br J Dermatol 1989; 121:51-7. (Pubitemid 19177120)
24. Miller YW, Eady EA, Lacey RW, et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996;38:829-37. (Pubitemid 26413718)
25. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995;63:3158-65.
26. Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
27. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78. (Pubitemid 36461325)
28. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and pres - Cribers. Am J Clin Dermatol 2003;4:813-31. (Pubitemid 38030858)
29. Samuelson JS. An accurate photographic method for grading acne: initial use in a double-blind clinical comparison of minocycline and tetracycline. J Am Acad Dermatol 1985;12:461-7. (Pubitemid 15144630)
30. Cibula D, Hill M, Vohradnikova O, et al. The role of androgens in determining acne severity in adult women. Br J Dermatol 2000;143:399-404. (Pubitemid 30650412)
31. Worret I, Arp W, Zahradnik HP, et al. Acne resolution rates: results of a singleblind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology 2001;203:38-44. (Pubitemid 32830529)
32. Rosen MP, Breitkopf DM, Nagamani M. A randomized controlled trial of secondversus third-generation oral contraceptives in the treatment of acne vulgaris. Am J Obstet Gynecol 2003;188:1158-60. (Pubitemid 36589087)
33. ACOG practice bulletin no.110: noncontraceptive uses of hormonal contracep - Tives. Obstet Gynecol 2010;115:206-18.
34. Van Vloten WA, van Haselen CW, van Zuuren EJ, et al. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002;69(suppl4):2-15.
35. Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984;111:209-14. (Pubitemid 14052303)
36. Miller JA, Wojnarowska FT, Dowd PM, et al. Anti-androgen treatment in women with acne: a controlled trial. Br J Dermatol 1986;114:705-16. (Pubitemid 16079772)
37. Shaw JC, White LE. Long-term safety of spironolactone in acne: results of an 8-year follow-up study. J Cutan Med Surg 2002;6:541-5. (Pubitemid 36091499)
38. Wolverton SE. Comprehensive dermatologic drug therapy. 2nd ed. Philadelphia: WB Saunders; 2007.
39. Health Canada. Health Canada endorsed important safety information on Accutane Roche isotretinoin). Available http://hc-sc.gc.ca/dhp-mps/medeff/ advisoriesavis/prof/-2010/accutane-2-hpc-cps-eng.php (accessed 2010 Sep. 7).
40. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide. Am J Clin Dermatol 2003;4:493-505. (Pubitemid 36871767)
41. Product monograph. Accutane Roche. Mississauga (ON): Hoffmann-La Roche. 2010.
42. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment. Br J Dermatol 1993;129:292-6. (Pubitemid 23284001)
43. Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoyl peroxide in the treatment of acne. Med J Aust 1990;153:455-8. (Pubitemid 20332232)
44. Jordan R, Cummins CCL, Burls A, et al. Laser resurfacing for facial acne scars. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No. CD001866. DOI:10.1002/14651858.CD001866.
45. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999;25:18-22. (Pubitemid 29242727)
46. Levine RM, Rasmussen JE. Intralesional corticosteroids in the treatment of nod - Ulocystic acne. Arch Dermatol 1983;119:480-1. (Pubitemid 13100112)
47. Raimer S, Maloney JM, Bourcier M, et al. United States/Canada Dapsone Gel Study Group. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis 2008;81:171-8.
48. Piette WW, Taylor S, Pariser D, et al. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Arch Dermatol 2008;144:1564-70.